Li, Y. (2026) “FDA Regulatory Milestones, Announcement Framing, and Biotechnology Stock Returns: Evidence on the Feasibility of an AI-Native Comparison, 2019-2026”, Highlights in Business, Economics and Management, 70, pp. 94–102. doi:10.54097/n6naqe96.